Wounds are one of the most common health issues, and the cost of wound care and healing
has continued to increase over the past decade. The first step in wound healing is …

The challenge for the treatment of severe traumas poses an urgent clinical need for the
development of biomaterials to achieve rapid hemostasis and wound healing. In the past …

A growth in the use of antibiotics and the related evolution of patients' drug resistance calls
for an urgent response for the development of novel curing approaches without using …

Currently used wound dressings are ineffective. Hence, there is a need to develop introduce
a high‐performance medicament with multiple functions including rapid hemostasis and …

Bacteria‐induced epidemics and infectious diseases are seriously threatening the health of
people around the world. In addition, antibiotic therapy has been inducing increasingly more …

The production of reactive oxygen species, persistent inflammation, bacterial infection, and
recurrence after a tumor resection has become the main challenge in cancer therapy and …

Silicon nanomaterials are one of the most representative inorganic nanomedicines in
therapeutic biomedicine. Silicon quantum dots (Si QDs) have aroused wide attention in the …

Effectively targeting and killing microbial pathogens is a major challenge in the treatment of
infectious diseases. Inspired by the high efficacy of natural antimicrobial peptides (AMPs), in …

The invention of silica-based bioactive glass in the late 1960s has sparked significant
interest in exploring a wide range of silicon-containing biomaterials from the macroscale to …

Pathogenic infections have emerged as major threats to global public health. Multidrug
resistance induced by the abuse of antibiotics makes the anti-infection therapies to be a …